United Kingdom

People: Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

24 May 2019
Change (% chg)

$-0.19 (-4.51%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cherry, Joel 

Dr. Joel Cherry, Ph.D. is no longer President - Research and Development of Amyris, Inc., effective June 7, 2019. Dr. Cherry previously served as Senior Vice President of Research Programs and Operations since November 2008. Before joining Amyris, Dr. Cherry was Senior Director of Bioenergy Biotechnology at Novozymes, a biotechnology company focusing on development and manufacture of industrial enzymes from 1992 to November 2008. At Novozymes, he served in a variety of R&D scientific and management positions, including membership in Novozymes’ International R&D Management team, and as Principal Investigator and Director of the BioEnergy Project, a U.S. Department of Energy-funded $18 million effort initiated in 2000. Dr. Cherry holds a Bachelor of Arts degree in Chemistry from Carleton College and a Doctor of Philosophy degree in Biochemistry from the University of New Hampshire.

Basic Compensation

Total Annual Compensation, USD 370,937
Restricted Stock Award, USD 118,718
Long-Term Incentive Plans, USD --
All Other, USD 224,320
Fiscal Year Total, USD 713,975

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --